Emily Bristow

Significant biosimilar activities this week include 20 Jul 20 | EU | Spherix reported that the EU market for AbbVie's...

Significant biosimilar activities this week include 09 Jul 20 | AU | The Australian Generic and Biosimilar Medicines...

Significant biosimilar activities this week include 05 Jul 20 | In its 2019-2020 Annual Report, Biocon announced it...

Significant biosimilar activities this week include 28 Jun 20 | US Genentech filed a complaint against Samsung...

Significant biosimilar activities this week include June 20 | The NZ Herald reported a new study by NZ scientists...

Significant biosimilar activities this week include 08 Jun 20 | The Centre for Biosimilars reported that the WHO...

Significant biosimilar activities this week include 29 May 20 | In a filing to the Securities and Exchange...

Significant biosimilar activities this week include 25 May 20 | The American Journal of Managed Care reported two cost...

Significant biosimilar activities this week include 11 May 20 | AstraZeneca announced it had recovered the global...

Significant biosimilar activities this week include 11 May 20 | Healio reported on a new study comparing faricimab to...

Significant biosimilar activities this week include 01 May 2020 | AbbVie released its Q1 2020 financial results,...

Significant biosimilar activities this week include 23 April 2020 | Henlius Biotech announced it has received two EU...

Significant biosimilar activities this week include 21 Apr 20 | The Centre for Biosimilars reported that Xbrane Pharma...

Significant biosimilar activities this week include 14 April 20 | Mylan and Biocon launched Fulphila® (pegfilgrastim)...

Significant biosimilar activities this week include March 20 | BiosanaPharma released the results of Ph I trials of...

Significant biosimilar activities this week include 30 Mar 20 | Biocad announced it had received registration...